@prefix dcterms: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix mgi: . @prefix proteinModification: . @prefix psimod: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 belv:variantOf mgi:1346858; a proteinModification:, psimod:00696 . sub:_2 occursIn: species:10090; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:23965; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:estradiol) -> p(MGI:Mapk1,pmod(P))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "E2 at 10-8M specifically induced the rapid phosphorylation of ERK2. The E2-specific phosphorylation of ERK2 could be blocked by the specific MAPK inhibitor, PD98059. The kinetic profile of the phosphorylation of ERK2 was consistent with that of the enhancement of the sAPP release."; prov:wasQuotedFrom pubmed:11488923 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11488923; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dcterms:created "2014-07-03T14:29:57.742+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }